Partners' Directory

  Home   Search   Join the Partnership   Login

Contact General Specializations in Countries Contribution to the Global Plan Declaration

View this partner's profile

Organization Contact Information

Name: Eli Lilly Export S.A.
Street 1: Chemin des Coquelicots 16
Street 2:
City: Geneva
Province:
Post Code: 1214 Vernier
Country: Switzerland
Phone: +41 22 306 0320
Email: chaler_monica@lilly.com
Web Site: http://www.LillyGlobalHealth.com

Focal Point Contact Information

Salutation: Mr
First Name: Evan
Last Name: Lee
Title: Director, Infectious Diseases
Email: lee_evan@lilly.com
Phone: +41 22 306 0320

Alternate Focal Point Contact Information

Salutation: Ms
First Name: Monica
Last Name: Chaler
Title: Institutional Relations
Email: chaler_monica@lilly.com
Phone:  

General Information

Board Constituency: Private sector
Organization Type - Primary: Private Sector
Organization Type - Secondary: Company
Is your organization legally registered in your country: Yes
Organization Reach: International
Organization Description:
Recognizing that MDR-TB cannot be halted by medicine alone, Lilly created the Lilly MDR-TB
Partnership in 2003. This public-private initiative mobilizes over 20 partners on five continents to
tackle the scourge of TB and MDR-TB. Eli Lilly and Company is contributing US$ 120 million in cash,
medicines, advocacy tools and technology to focus global resources on prevention, diagnosis and
treatment of TB and MDR-TB. An additional US$ 15 million was given to the Lilly TB Drug Discovery
Initiative; a nonprofit with the goal of accelerating the discovery of new drugs to treat TB by bringing
together specialists from around the world. The company has made this investment to ensure that
thousands of MDR-TB patients receive the care and medication they need to combat this disease.
 
Total number of staff in your organization: 100 +
Number of full-time staff who are directly involved with TB: 6 - 10
Number of part-time staff who are directly involved with TB: 1 - 5
Number of volunteers who are directly involved with TB: 1 - 5
 
What is your organization's annual budget (USD) dedicated to TB? $1 MIL-$10 MIL
How did you hear about the Stop TB Partnership: Other partners
If you were informed or referred by another partner of the Stop TB Partnership please tell us who:
Why do you wish join the Stop TB Partnership: Technical assistance and advice
 
Are you a member of a Stop TB national partnership: No
Are you in contact with your national TB programme: No
Please tell us how your organization is contributing to your country's national TB control plan:
In our four focus countries (China, India, Russia and South Africa), we work closely with a number of local partners including the national Ministries of Health to support the national TB control plan.
 

Geographical Reach

Which country is your headquarters located in: United States of America
Which WHO region is the main focus of your work: Global
Which countries do you do operate in:
(This includes countries you are conducting activities in)
China
India
Russian Federation
South Africa
Switzerland
United States of America

Specializations

Advocacy
Funding, including innovative and optimized approach to funding TB Care
Provision of drugs, diagnostics and commodities
Research and Development

Specializations in Countries

Advocacy China
Advocacy India
Advocacy Russian Federation
Advocacy South Africa
Funding, including innovative and optimized approach to funding TB Care China
Funding, including innovative and optimized approach to funding TB Care India
Funding, including innovative and optimized approach to funding TB Care Russian Federation
Funding, including innovative and optimized approach to funding TB Care South Africa
Funding, including innovative and optimized approach to funding TB Care Switzerland
Funding, including innovative and optimized approach to funding TB Care United States of America
Provision of drugs, diagnostics and commodities China
Provision of drugs, diagnostics and commodities India
Provision of drugs, diagnostics and commodities Russian Federation
Provision of drugs, diagnostics and commodities South Africa
Research and Development United States of America

Contribution

Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below:

TB Care Delivery:
see www.lillymdr-tb.com

Drug-Resistant TB:
see www.lillymdr-tb.com

Research:
see www.lillymdr-tb.com

Declaration

Declaration of interests:
No conflicts of interest were delacred.

Application date:  
Last updated: May 11, 2017